LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0016667
90.74 17.25 10809 6109 1.7692 1.1394
MN20160310_N02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
92.71 17.25 43 6184 0.0070 0.1136
MN20160310_N02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
92.71 17.25 11609 6184 1.8772 1.1541
MN20160310_N02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
92.71 17.25 7930 6184 1.2823 1.0595
MN20160310_N02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
92.71 17.25 11052 6184 1.7872 1.1416
MN20160310_N02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
94.68 17.25 22 6239 0.0035 0.0290
MN20160310_N02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
94.68 17.25 11964 6239 1.9175 1.1592
MN20160310_N02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
94.68 17.25 6753 6239 1.0823 1.0187
MN20160310_N02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
94.68 17.25 11396 6239 1.8265 1.1469
MN20160310_N02
L04
MCF 10A-H2B-mCherry Trametinib
0.003
3.06 17.25 1 143 0.0070 -0.6065
MN20160310_N02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
3.06 17.25 243 143 1.6968 1.3781
MN20160310_N02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
3.06 17.25 1 143 0.0070 -0.6065
MN20160310_N02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
3.06 17.25 223 143 1.5571 1.3121
MN20160310_N02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
3.06 17.25 1 143 0.0070 -0.6065
MN20160310_N02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
3.06 17.25 446 143 3.1142 1.9014
MN20160310_N02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
5.03 17.25 1 273 0.0037 -0.5106
MN20160310_N02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
5.03 17.25 464 273 1.6974 1.2839
MN20160310_N02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
5.03 17.25 1 273 0.0037 -0.5106
MN20160310_N02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
5.03 17.25 429 273 1.5694 1.2394
MN20160310_N02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
5.03 17.25 1 273 0.0037 -0.5106
MN20160310_N02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
5.03 17.25 773 273 2.8278 1.5959
MN20160310_N02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
7.01 17.25 1 389 0.0026 -0.4692
MN20160310_N02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
7.01 17.25 679 389 1.7433 1.2631
MN20160310_N02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
7.01 17.25 1 389 0.0026 -0.4692
MN20160310_N02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
7.01 17.25 866 389 2.2234 1.3889
MN20160310_N02
K07